Rankings
▼
Calendar
TARA Q3 2023 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TARA
Protara Therapeutics, Inc.
$228M
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$11M
Net Income
-$10M
EPS (Diluted)
$-0.87
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$88M
Total Liabilities
$12M
Stockholders' Equity
$77M
Cash & Equivalents
$34M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$11M
-$8M
-34.2%
Net Income
-$10M
-$8M
-28.2%
← FY 2023
All Quarters
Q4 2023 →